128 related articles for article (PubMed ID: 8721646)
1. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.
Lip GY; Lowe GD; Rumley A; Dunn FG
Am Heart J; 1996 Apr; 131(4):724-30. PubMed ID: 8721646
[TBL] [Abstract][Full Text] [Related]
2. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
Lip GY; Lowe GD; Rumley A; Dunn FG
Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
[TBL] [Abstract][Full Text] [Related]
3. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.
Lip GY; Rumley A; Dunn FG; Lowe GD
Int J Cardiol; 1995 Oct; 51(3):245-51. PubMed ID: 8586473
[TBL] [Abstract][Full Text] [Related]
4. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
[TBL] [Abstract][Full Text] [Related]
5. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
6. A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation.
Kamath S; Chin BS; Blann AD; Lip GY
Blood Coagul Fibrinolysis; 2002 Oct; 13(7):627-36. PubMed ID: 12439149
[TBL] [Abstract][Full Text] [Related]
7. Thrombogenesis in mitral regurgitation and aortic stenosis.
Lip GY; Rumley A; Dunn FG; Lowe GD
Angiology; 1996 Dec; 47(12):1117-25. PubMed ID: 8956663
[TBL] [Abstract][Full Text] [Related]
8. Low serum albumin levels in patients with paroxysmal atrial fibrillation: what does it mean?
He YM; Yang XJ; Hui J; Jiang TB; Song JP; Liu ZH; Jiang WP
Acta Cardiol; 2006 Jun; 61(3):333-7. PubMed ID: 16869456
[TBL] [Abstract][Full Text] [Related]
9. [Plasma electrolytes in patients with paroxysmal supraventricular arrhythmia].
Poleszak K
Wiad Lek; 1993 Aug; 46(15-16):561-7. PubMed ID: 7975578
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
[TBL] [Abstract][Full Text] [Related]
11. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
Lip GY; Lip PL; Zarifis J; Watson RD; Bareford D; Lowe GD; Beevers DG
Circulation; 1996 Aug; 94(3):425-31. PubMed ID: 8759084
[TBL] [Abstract][Full Text] [Related]
12. Correlation of paroxysmal supraventricular tachycardia, atrial fibrillation, and sinus rhythm with incidences of new thromboembolic stroke in 1476 old-old patients.
Aronow WS; Ahn C; Mercando AD; Epstein S; Gutstein H
Aging (Milano); 1996 Feb; 8(1):32-4. PubMed ID: 8695673
[TBL] [Abstract][Full Text] [Related]
13. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
Li-Saw-Hee FL; Blann AD; Goldsmith I; Lip GY
Am J Cardiol; 1999 Apr; 83(8):1206-9. PubMed ID: 10215285
[TBL] [Abstract][Full Text] [Related]
14. Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients.
Yashiro Y; Arimoto T; Hashimoto N; Tamura H; Iwayama T; Ishigaki D; Kumagai Y; Nishiyama S; Takahashi H; Shishido T; Miyamoto T; Watanabe T; Kubota I
Circ J; 2015; 79(1):61-9. PubMed ID: 25391906
[TBL] [Abstract][Full Text] [Related]
15. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
[TBL] [Abstract][Full Text] [Related]
16. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
Drabik L; Wołkow P; Undas A
Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
[TBL] [Abstract][Full Text] [Related]
17. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
Marín F; Roldán V; Climent VE; Ibáñez A; García A; Marco P; Sogorb F; Lip GY
Heart; 2004 Oct; 90(10):1162-6. PubMed ID: 15367514
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
19. The signal-averaged P-wave duration is longer in hypertensive patients with history of paroxysmal atrial fibrillation as compared to those without.
Aytemir K; Amasyali B; Abali G; Kose S; Kilic A; Onalan O; Tokgozoglu L; Kabakci G; Ozkutlu H; Nazli N; Isik E; Oto A
Int J Cardiol; 2005 Aug; 103(1):37-40. PubMed ID: 16061121
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
